NCM · Biotechnology

Outlook Therapeutics, Inc. (OTLK) Stock

$0.56 -4.41% NCM: OTLK Healthcare

Valuation

MetricValue
Price$0.56
Market Cap$105.47M
P/E Ratio-0.32
P/B Ratio-1.45
P/S Ratio-94.85
EPS (TTM)$-1.79
52-Week High$2.54
52-Week Low$0.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE222.01%
ROA-233.43%
ROCE248.15%
Gross Margin-6700.00%
Operating Margin-6700.00%
Net Margin-0.05%
Debt/Equity-1.77
Current Ratio0.37

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-52.0M$-63.0M$-53.0M$-72.0M$-67.0M
Net Profit$-53.0M$-66.0M$-59.0M$-75.0M$-62.0M
EPS$-7.00$-6.23$-4.80$-4.06$-1.79
Op Margin————-4744.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.0M$29.0M$32.0M$29.0M$19.0M
Total Liabilities$18.0M$20.0M$47.0M$102.0M$51.0M
Cash$14.0M$17.0M$23.0M$15.0M$8.0M
Borrowings$12.0M$11.0M$36.0M$30.0M$30.0M

Latest News

Outlook Therapeutics Registers 17.3 Million Shares for Resale MT Newswires · Jul 17, 2026 Outlook Therapeutics (OTLK) Gets July 29 PDUFA Date for LYTENAVA Insider Monkey · Jul 14, 2026 Outlook Therapeutics Regains Nasdaq Compliance MT Newswires · Jun 29, 2026 OTLK Stock Up 35% as FDA Accepts Resubmitted Eye Drug BLA for Review Zacks · Jun 17, 2026 Outlook Therapeutics (OTLK) Stock After FDA Review Win Is The Valuation Case Already Priced In Simply Wall St. · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-54.0M$-57.0M$-43.0M$-69.0M$-52.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$4.0M$0$-1.0M$0$0
Net Cash Flow$2.0M$3.0M$6.0M$-8.0M$-7.0M
Free Cash Flow$-54.0M$-57.0M$-43.0M$-69.0M$-52.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.89
FCF Yield-51.78%
Quick Ratio0.63
Interest Coverage-210.62
Return 1Y-30.84%
Return 3Y-95.24%
Return 5Y-96.50%

Ownership

Insiders Held17.42%
Institutions Held6.94%
Institutions Float Held8.40%
Institutional HolderSharesReport Date
Armistice Capital, LLC4,168,0002026-03-31
Vanguard Capital Management LLC1,967,1602026-03-31
Geode Capital Management, LLC603,6062026-03-31
Gilpin Wealth Management, LLC600,1622026-03-31
Commonwealth Equity Services, LLC470,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
COEPCoeptis Therapeutics Holdings, Inc. $10.99 -8.57% -4.45 $38.62M 0.00%
CUECue Biopharma, Inc. $22.33 -0.80% -0.95 $162.21M 0.00%
EQEquillium, Inc. $1.44 +3.60% -5.50 $91.05M 0.00%
HOWLWerewolf Therapeutics, Inc. $0.91 -1.10% -1.26 $44.22M 0.00%
IOBTIO Biotech, Inc. $0.01 -27.59% -0.01 $885690 0.00%

About Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. is led by CEO Robert Charles Jahr, employs 23 people, headquartered in US, publicly traded since 2016.

Outlook Therapeutics, Inc. (OTLK) stock trades at $0.56 with a market capitalization of $105.47M. The stock is valued at a price-to-earnings (P/E) ratio of -0.32, price-to-book of -1.45, price-to-sales of -94.85. Over the past 52 weeks the stock has ranged between $0.16 and $2.54, and currently trades 78.0% below its 52-week high.

On profitability, Outlook Therapeutics, Inc. generates a return on equity (ROE) of 222.01% — well above the market average, a sign of a high-quality business, return on capital employed of 248.15%, an operating margin of -6700.00%, a net profit margin of -0.05%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1162.55 -0.60% JNJ Johnson & Johnson $257.43 +0.37% ABBV AbbVie Inc. $274.33 +0.70% MRK Merck & Company, Inc. Common Stock (new) $143.09 +0.50% UNH UnitedHealth Group Incorporated Common Stock (DE) $383.12 +3.28% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $656.23 +0.65% AMGN Amgen Inc. $406.05 -0.34% GILD Gilead Sciences, Inc. $147.20 +0.07% ABT Abbott Laboratories $100.17 +1.71% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides